 NEW YORK, March 17, 2021 GLOBE NEWSWIRE -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Aquestive Therapeutics, Inc. Aquestive or the Company NASDAQ: AQST from December 2, 2019, through September 25, 2020 the Class Period. The lawsuit filed in the United States District Court for the District of New Jersey alleges violations of the Securities Exchange Act of 1934. 